Motealleh A, Kehr NS. Injectable oxygen-generating nanocomposite hydrogels with prolonged oxygen delivery for enhanced cell proliferation under hypoxic and normoxic conditions. J Mater Chem B. 2020;8(19):4195–201.
Google Scholar
Ashammakhi N, et al. Advances in controlled oxygen generating biomaterials for tissue engineering and regenerative therapy. Biomacromol. 2020;21(1):56–72.
Google Scholar
Biro GP. Oxygen and ATP: the Energy Economy of the Cell. In: Liu H, Kaye AD, Jahr JS, editors. Blood substitutes and oxygen biotherapeutics. Cham: Springer International Publishing; 2022. p. 21–32.
Google Scholar
Werner M, et al. Femoral blood gas analysis, another tool to assess hemorrhage severity following trauma: an exploratory prospective study. Scand J Trauma Resusc Emerg Med. 2023;31(1):31.
Google Scholar
Dyer WB, et al. Recovery of organ-specific tissue oxygen delivery at restrictive transfusion thresholds after fluid treatment in ovine haemorrhagic shock. Intensive Care Med Exp. 2022;10(1):12.
Google Scholar
Chen WR, Chou CC, Wang CC. Phthalides serve as potent modulators to boost fetal hemoglobin induction therapy for β-hemoglobinopathies. Blood Adv. 2019;3(9):1493–8.
Google Scholar
Hönemann JN, et al. Hypoxia and cardiac function in patients with prior myocardial infarction. Circ Res. 2023;132(9):1165–7.
Google Scholar
Kabra R, et al. Hidden mystery behind unilateral cerebellar infarction in hanging: a case report. Cureus. 2022;14(11):e31115.
Google Scholar
Köhler D, et al. Hypoxic, anemic and cardiac hypoxemia: When does tissue hypoxia begin? Dtsch Med Wochenschr. 2023;148(8):475–82.
Google Scholar
Godoy DA, et al. Avoiding brain hypoxia in severe traumatic brain injury in settings with limited resources—a pathophysiological guide. J Crit Care. 2023;75:154260.
Google Scholar
Haddon A, et al. Cardiorespiratory responses to voluntary hyperventilation during normobaric hypoxia. Aerosp Med Hum Perform. 2023;94(2):59–65.
Google Scholar
Wang L, et al. Shen Shuai II recipe inhibits hypoxia-induced glycolysis by preserving mitochondrial dynamics to attenuate kidney fibrosis. J Ethnopharmacol. 2023;308:116271.
Google Scholar
Biro GP. Erythrocyte transfusion: brief history and current practice. In: Liu H, Kaye AD, Jahr JS, editors. Blood substitutes and oxygen biotherapeutics. Cham: Springer International Publishing; 2022. p. 3–19.
Google Scholar
Lee P, Chandel NS, Simon MC. Cellular adaptation to hypoxia through hypoxia inducible factors and beyond. Nat Rev Mol Cell Biol. 2020;21(5):268–83.
Google Scholar
Chen Z, et al. Hypoxic microenvironment in cancer: molecular mechanisms and therapeutic interventions. Signal Transduct Target Ther. 2023;8(1):70.
Google Scholar
Li B, et al. PEG-conjugated bovine haemoglobin enhances efficiency of chemotherapeutic agent doxorubicin with alleviating DOX-induced splenocardiac toxicity in the breast cancer. Artif Cells Nanomed Biotechnol. 2023;51(1):120–30.
Google Scholar
Luo Z, et al. Hypoxia signaling in human health and diseases: implications and prospects for therapeutics. Signal Transduct Target Ther. 2022;7(1):218.
Google Scholar
Cherian VT. Physiological functions of blood. In: Liu H, Kaye AD, Jahr JS, editors. Blood substitutes and oxygen biotherapeutics. Cham: Springer International Publishing; 2022. p. 33–43.
Google Scholar
Cohn EJ. Blood: a brief survey of its chemical components and of their natural functions and clinical uses. Blood. 2015;126(24):2531.
Google Scholar
Mohanto N, Park YJ, Jee JP. Current perspectives of artificial oxygen carriers as red blood cell substitutes: a review of old to cutting-edge technologies using in vitro and in vivo assessments. J Pharm Investig. 2023;53(1):153–90.
Google Scholar
Ahmed MH, Ghatge MS, Safo MK. Hemoglobin: structure, function and allostery. In: Hoeger U, Harris JR, editors. Vertebrate and invertebrate respiratory proteins, lipoproteins and other body fluid proteins. Cham: Springer International Publishing; 2020. p. 345–82.
Google Scholar
Shu P, et al. Cefmetazole sodium as an allosteric effector that regulates the oxygen supply efficiency of adult hemoglobin. J Biomol Struct Dyn. 2023. https://doi.org/10.1080/07391102.2023.2245043.
Google Scholar
Yu S. Hemoglobin: physiology and hemoglobinopathy. In: Liu H, Kaye AD, Jahr JS, editors. Blood substitutes and oxygen biotherapeutics. Cham: Springer International Publishing; 2022. p. 45–51.
Google Scholar
Liu WL, et al. Aggressive man-made red blood cells for hypoxia-resistant photodynamic therapy. Adv Mater. 2018;30(35):e1802006.
Google Scholar
Zujalovic B, Hafner S. Damage control resuscitation: identification and treatment of life-threatening hemorrhage. Anesth Analg. 2020;130(5):e141–2.
Google Scholar
Carreau A, et al. Why is the partial oxygen pressure of human tissues a crucial parameter? Small molecules and hypoxia. J Cell Mol Med. 2011;15(6):1239–53.
Google Scholar
Haque N, et al. Hypoxic culture conditions as a solution for mesenchymal stem cell based regenerative therapy. Sci World J. 2013;2013:632972.
Google Scholar
Khan F, Singh K, Friedman MT. Artificial blood: the history and current perspectives of blood substitutes. Discoveries (Craiova). 2020;8(1):e104.
Google Scholar
Bialas C, Moser C, Sims CA. Artificial oxygen carriers and red blood cell substitutes: A historic overview and recent developments toward military and clinical relevance. J Trauma Acute Care Surg. 2019;87(1S):S48-s58.
Google Scholar
Stanworth SJ, et al. Effects of the COVID-19 pandemic on supply and use of blood for transfusion. Lancet Haematol. 2020;7(10):e756–64.
Google Scholar
Coll-Satue C, et al. Stepping stones to the future of haemoglobin-based blood products: clinical, preclinical and innovative examples. Biomater Sci. 2021;9(4):1135–52.
Google Scholar
Dumont LJ, et al. Overnight, room temperature hold of whole blood followed by 42-day storage of red blood cells in additive solution-7. Transfusion. 2015;55(3):485–90.
Google Scholar
Brand A. Immunological complications of blood transfusions. Presse Med. 2016;45(7–8 Pt 2):e313–24.
Google Scholar
Xia S, et al. Addition of sodium pyruvate to stored red blood cells attenuates liver injury in a murine transfusion model. Mediators Inflamm. 2016;2016:3549207.
Google Scholar
Charbe NB, et al. A new era in oxygen therapeutics? From perfluorocarbon systems to haemoglobin-based oxygen carriers. Blood Rev. 2022;54:100927.
Google Scholar
Rangayasami A, et al. Influence of nanotechnology to combat against COVID-19 for global health emergency: a review. Sensors International. 2021;2:100079.
Google Scholar
Berg L, et al. Obstetric outcomes in Jehovah’s Witnesses: case series over nine years in a London teaching hospital. Arch Gynecol Obstet. 2023. https://doi.org/10.1007/s00404-023-06940-x.
Google Scholar
Naicker YD, Ahmed N, Davids R. Damage control surgery of the critical Jehovah’s Witness patient—a narrative review. S Afr J Surg. 2023;61(1):39–44.
Google Scholar
Liu H, et al. Classifications of blood substitutes. In: Liu H, Kaye AD, Jahr JS, editors., et al., Blood substitutes and oxygen biotherapeutics. Cham: Springer International Publishing; 2022. p. 119–29.
Google Scholar
Jahr JS, et al. Blood substitutes and oxygen therapeutics: a review. Anesth Analg. 2021;132(1):119–29.
Google Scholar
Wu L, et al. Perfluorocarbons-based (19)F magnetic resonance imaging in biomedicine. Int J Nanomed. 2020;15:7377–95.
Google Scholar
Castro CI, Briceno JC. Perfluorocarbon-based oxygen carriers: review of products and trials. Artif Organs. 2010;34(8):622–34.
Google Scholar
Park KM, Gerecht S. Hypoxia-inducible hydrogels. Nat Commun. 2014;5:4075.
Google Scholar
Spahn DR, Kocian R. Artificial O2 carriers: status in 2005. Curr Pharm Des. 2005;11(31):4099–114.
Google Scholar
Chen L, Yang Z, Liu H. Hemoglobin-based oxygen carriers: where are we now in 2023? Med (Kaunas). 2023. https://doi.org/10.3390/medicina59020396.
Google Scholar
Mer M, et al. Hemoglobin glutamer-250 (bovine) in South Africa: consensus usage guidelines from clinician experts who have treated patients. Transfusion. 2016;56(10):2631–6.
Google Scholar
Cao M, et al. New applications of HBOC-201: a 25-year review of the literature. Front Med (Lausanne). 2021;8:794561.
Google Scholar
Romito BT, et al. The effect of SANGUINATE(®) (PEGylated carboxyhemoglobin bovine) on cardiopulmonary bypass functionality using a bovine whole blood model of normovolemic hemodilution. Perfusion. 2020;35(1):19–25.
Google Scholar
Marrazzo F, et al. Inhaled nitric oxide prevents systemic and pulmonary vasoconstriction due to hemoglobin-based oxygen carrier infusion: A case report. J Crit Care. 2019;51:213–6.
Google Scholar
Wang Y, et al. Structural, functional and physiochemical properties of dextran-bovine hemoglobin conjugate as a hemoglobin-based oxygen carrier. Process Biochem. 2017;60:67–73.
Google Scholar
Huo S, et al. Ferrous hemoglobin and hemoglobin-based oxygen carriers acting as a peroxidase can inhibit oxidative damage to endothelial cells caused by hydrogen peroxide. Artif Organs. 2021;45(10):1229–39.
Google Scholar
Li T, Jing X, Huang Y. Polymer/hemoglobin assemblies: biodegradable oxygen carriers for artificial red blood cells. Macromol Biosci. 2011;11(7):865–75.
Google Scholar
Moradi S, Jahanian-Najafabadi A, Roudkenar MH. Artificial blood substitutes: first steps on the long route to clinical utility. Clin Med Insights Blood Disord. 2016;9:33–41.
Google Scholar
Sen Gupta A. Hemoglobin-based oxygen carriers: current state-of-the-art and novel molecules. Shock. 2019;52(1S):70–83.
Google Scholar
Wang Y, et al. A PEGylated bovine hemoglobin as a potent hemoglobin-based oxygen carrier. Biotechnol Prog. 2017;33(1):252–60.
Google Scholar
Bian Y, Chang TM. A novel nanobiotherapeutic poly-[hemoglobin-superoxide dismutase-catalase-carbonic anhydrase] with no cardiac toxicity for the resuscitation of a rat model with 90 minutes of sustained severe hemorrhagic shock with loss of 2/3 blood volume. Artif Cells Nanomed Biotechnol. 2015;43(1):1–9.
Google Scholar
Chang TM. Blood replacement with nanobiotechnologically engineered hemoglobin and hemoglobin nanocapsules. Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2010;2(4):418–30.
Google Scholar
Bian Y, Chang TMS. Nanobiotechnological basis of an oxygen carrier with enhanced carbonic anhydrase for CO(2) transport and enhanced catalase and superoxide dismutase for antioxidant function. Front Bioeng Biotechnol. 2023;11:1188399.
Google Scholar
Mitchell MJ, et al. Engineering precision nanoparticles for drug delivery. Nat Rev Drug Discov. 2021;20(2):101–24.
Google Scholar
Bäumler H, Xiong Y, Georgieva R. Nanotechnology-based oxygen and drug carriers. In: Liu H, Kaye AD, Jahr JS, editors. Blood substitutes and oxygen biotherapeutics. Cham: Springer International Publishing; 2022. p. 169–73.
Google Scholar
Modery-Pawlowski CL, et al. Synthetic approaches to RBC mimicry and oxygen carrier systems. Biomacromol. 2013;14(4):939–48.
Google Scholar
Liu X, et al. Low-fouling electrosprayed hemoglobin nanoparticles with antioxidant protection as promising oxygen carriers. Macromol Biosci. 2020;20(2):e1900293.
Google Scholar
Nadimifar M, et al. Synthesis of bioactive hemoglobin-based oxygen carrier nanoparticles via metal-phenolic complexation. Biomater Adv. 2024;156:213698.
Google Scholar
Chang TMS. A brief history of the development of nanobiotechnology-based blood substitutes. In: Liu H, Kaye AD, Jahr JS, editors. Blood substitutes and oxygen biotherapeutics. Cham: Springer International Publishing; 2022. p. 99–115.
Google Scholar
Matsuhira T, Sakai H. Artificial oxygen carriers, from nanometer- to micrometer-sized particles, made of hemoglobin composites substituting for red blood cells. Particuology. 2022;64:43–55.
Google Scholar
Jia Y, Duan L, Li J. Hemoglobin-based nanoarchitectonic assemblies as oxygen carriers. Adv Mater. 2016;28(6):1312–8.
Google Scholar
Tao Z, Ghoroghchian PP. Microparticle, nanoparticle, and stem cell-based oxygen carriers as advanced blood substitutes. Trends Biotechnol. 2014;32(9):466–73.
Google Scholar
Jansman MMT, Hosta-Rigau L. Recent and prominent examples of nano- and microarchitectures as hemoglobin-based oxygen carriers. Adv Colloid Interface Sci. 2018;260:65–84.
Google Scholar
Kaneda S, et al. Liposome-encapsulated hemoglobin, TRM-645: current status of the development and important issues for clinical application. Artif Organs. 2009;33(2):146–52.
Google Scholar
Lu M, et al. Preparation, characterization and in vivo investigation of blood-compatible hemoglobin-loaded nanoparticles as oxygen carriers. Colloid Surf B Biointerfaces. 2016;139:171–9.
Google Scholar
Xu X, et al. A photosensitizer loaded hemoglobin-polymer conjugate as a nanocarrier for enhanced photodynamic therapy. J Mater Chem B. 2018;6(12):1825–33.
Google Scholar
Yuan M, et al. A robust oxygen-carrying hemoglobin-based natural sonosensitizer for sonodynamic cancer therapy. Nano Lett. 2021;21(14):6042–50.
Google Scholar
Pozy E, Savla C, Palmer AF. Photocatalytic synthesis of a polydopamine-coated acellular mega-hemoglobin as a potential oxygen therapeutic with antioxidant properties. Biomacromol. 2023;24(5):2022–9.
Google Scholar
Peng S, et al. Metal-organic framework encapsulating hemoglobin as a high-stable and long-circulating oxygen carriers to treat hemorrhagic shock. ACS Appl Mater Interfaces. 2019;11(39):35604–12.
Google Scholar
Cun X, et al. Hemoglobin-stabilized gold nanoclusters displaying oxygen transport ability, self-antioxidation, auto-fluorescence properties and long-term storage potential. RSC Adv. 2023;13(23):15540–53.
Google Scholar
Tang W, et al. Red blood cell-facilitated photodynamic therapy for cancer treatment. Adv Funct Mater. 2016;26(11):1757–68.
Google Scholar
Wang Q, et al. Bioinspired polydopamine-coated hemoglobin as potential oxygen carrier with antioxidant properties. Biomacromol. 2017;18(4):1333–41.
Google Scholar
Hu J, et al. Polydopamine-based surface modification of hemoglobin particles for stability enhancement of oxygen carriers. J Colloid Interface Sci. 2020;571:326–36.
Google Scholar
Li Y, et al. Artificial nonenzymatic antioxidant mxene nanosheet-anchored injectable hydrogel as a mild photothermal-controlled oxygen release platform for diabetic wound healing. ACS Nano. 2022;16(5):7486–502.
Google Scholar
Pan D, et al. Erythromer (EM), a nanoscale bio-synthetic artificial red cell: proof of concept and in vivo efficacy results. Blood. 2016;128(22):1027–1027.
Google Scholar
Liu P, et al. Bioinspired nanoerythrocytes for metabolic microenvironment remodeling and long-term prognosis promoting of acute ischemic stroke. Nano Today. 2023;49:101806.
Google Scholar
Bu H, et al. Synthesis of a hemoglobin-conjugated triblock copolymer for oxygen carrying and specific recognition of cancer cells. RSC Adv. 2017;7(76):48166–75.
Google Scholar
Tian H, et al. Cancer cell membrane-biomimetic oxygen nanocarrier for breaking hypoxia-induced chemoresistance. Adv Func Mater. 2017;27(38):1703197.
Google Scholar
Wang Y, et al. Engineering endogenous tumor-associated macrophage-targeted biomimetic nano-RBC to reprogram tumor immunosuppressive microenvironment for enhanced chemo-immunotherapy. Adv Mater. 2021;33(39):e2103497.
Google Scholar
Xia D, et al. Au-hemoglobin loaded platelet alleviating tumor hypoxia and enhancing the radiotherapy effect with low-dose X-ray. ACS Nano. 2020;14(11):15654–68.
Google Scholar
Zhang X, et al. Black phosphorus-loaded separable microneedles as responsive oxygen delivery carriers for wound healing. ACS Nano. 2020;14(5):5901–8.
Google Scholar
Munoz C, et al. Resuscitation after hemorrhagic shock in the microcirculation: targeting optimal oxygen delivery in the design of artificial blood substitutes. Front Med (Lausanne). 2020;7:585638.
Google Scholar
Chen G, et al. Effects of synthetic colloids on oxidative stress and inflammatory response in hemorrhagic shock: comparison of hydroxyethyl starch 130/0.4, hydroxyethyl starch 200/0.5, and succinylated gelatin. Crit Care. 2013;17(4):R141.
Google Scholar
Bragin DE, et al. Addition of drag-reducing polymers to colloid resuscitation fluid enhances cerebral microcirculation and tissue oxygenation after traumatic brain injury complicated by hemorrhagic shock. Adv Exp Med Biol. 2021;1269:283–8.
Google Scholar
Dyer WB, et al. An ovine model of hemorrhagic shock and resuscitation, to assess recovery of tissue oxygen delivery and oxygen debt, and inform patient blood management. Shock. 2021;56(6):1080–91.
Google Scholar
Hallisey SD, Greenwood JC. Beyond mean arterial pressure and lactate: perfusion end points for managing the shocked patient. Emerg Med Clin North Am. 2019;37(3):395–408.
Google Scholar
Yamamoto M, et al. Fluid resuscitation of hemorrhagic shock with hemoglobin vesicles in Beagle dogs: pilot study. Artif Cells Blood Substit Immobil Biotechnol. 2012;40(1–2):179–95.
Google Scholar
Yuki Y, et al. Efficacy of resuscitative infusion with hemoglobin vesicles in rabbits with massive obstetric hemorrhage. Am J Obstet Gynecol. 2021;224(4):398.e1-398.e11.
Google Scholar
Takase B, et al. Liposome-encapsulated hemoglobin (HbV) transfusion rescues rats undergoing progressive lethal 85% hemorrhage as a result of an anti-arrhythmogenic effect on the myocardium. Artif Organs. 2021;45(11):1391–404.
Google Scholar
Sakai H. Overview of potential clinical applications of hemoglobin vesicles (HbV) as artificial red cells, evidenced by preclinical studies of the academic research consortium. J Funct Biomater. 2017. https://doi.org/10.3390/jfb8010010.
Google Scholar
Fujihara M, et al. Primary and secondary immune responses to keyhole limpet hemocyanin in rats after infusion of hemoglobin vesicle, an artificial oxygen carrier. Artif Organs. 2014;38(3):234–8.
Google Scholar
Sakai H, et al. One-year observation of Wistar rats after intravenous infusion of hemoglobin-vesicles (artificial oxygen carriers). Artif Cells Blood Substit Immobil Biotechnol. 2007;35(1):81–91.
Google Scholar
Sakai H, et al. Metabolism of hemoglobin-vesicles (artificial oxygen carriers) and their influence on organ functions in a rat model. Biomaterials. 2004;25(18):4317–25.
Google Scholar
Sakai H, et al. Hemoglobin-vesicles as oxygen carriers: influence on phagocytic activity and histopathological changes in reticuloendothelial system. Am J Pathol. 2001;159(3):1079–88.
Google Scholar
Taguchi K, et al. Hepatically-metabolized and -excreted artificial oxygen carrier, hemoglobin vesicles, can be safely used under conditions of hepatic impairment. Toxicol Appl Pharmacol. 2010;248(3):234–41.
Google Scholar
Taguchi K, et al. Biological responsiveness and metabolic performance of liposome-encapsulated hemoglobin (Hemoglobin-Vesicles) in apolipoprotein E-deficient mice after massive intravenous injection. Biol Pharm Bull. 2015;38(10):1606–16.
Google Scholar
Shono S, et al. Intraosseous transfusion with liposome-encapsulated hemoglobin improves mouse survival after hypohemoglobinemic shock without scavenging nitric oxide. Shock. 2011;35(1):45–52.
Google Scholar
Eriksson M, et al. The effect of hemorrhagic shock and intraosseous adrenaline injection on the delivery of a subsequently administered drug – an experimental study. Scand J Trauma Resusc Emerg Med. 2019;27(1):29.
Google Scholar
Yadav VR, et al. Nanovesicular liposome-encapsulated hemoglobin (LEH) prevents multi-organ injuries in a rat model of hemorrhagic shock. Eur J Pharm Sci. 2016;93:97–106.
Google Scholar
Nag OK, et al. Post-modification of preformed liposomes with novel non-phospholipid poly(ethylene glycol)-conjugated hexadecylcarbamoylmethyl hexadecanoic acid for enhanced circulation persistence in vivo. Int J Pharm. 2013;446(1–2):119–29.
Google Scholar
Agashe H, et al. Improved formulation of liposome-encapsulated hemoglobin with an anionic non-phospholipid. Colloids Surf B Biointerfaces. 2010;75(2):573–83.
Google Scholar
Mittal N, et al. Erythromer (EM), a Nanoscale Bio-Synthetic Artificial Red Cell. In: Liu H, Kaye AD, Jahr JS, editors., et al., Blood substitutes and oxygen biotherapeutics. Cham: Springer International Publishing; 2022. p. 253–65.
Google Scholar
Okamoto W, et al. Hemoglobin–albumin clusters as an artificial O2 carrier: Physicochemical properties and resuscitation from hemorrhagic shock in rats. J Biomed Mater Res B Appl Biomater. 2022;110(8):1827–38.
Google Scholar
Liu Y, Ai K, Lu L. Polydopamine and its derivative materials: synthesis and promising applications in energy, environmental, and biomedical fields. Chem Rev. 2014;114(9):5057–115.
Google Scholar
Zhao Y, et al. Hollow PDA-Au nanoparticles-enabled signal amplification for sensitive nonenzymatic colorimetric immunodetection of carbohydrate antigen 125. Biosens Bioelectron. 2015;71:200–6.
Google Scholar
Baidukova O, et al. Antioxidative protection of haemoglobin microparticles (HbMPs) by PolyDopamine. Artif Cells Nanomed Biotechnol. 2018;46(sup3):S693-s701.
Google Scholar
Jansman MMT, et al. Hemoglobin-based oxygen carriers incorporating nanozymes for the depletion of reactive oxygen species. ACS Appl Mater Interfaces. 2020;12(45):50275–86.
Google Scholar
Liu X, et al. Metal-organic framework-based oxygen carriers with antioxidant activity resulting from the incorporation of gold nanozymes. Biomater Sci. 2023;11(7):2551–65.
Google Scholar
Lian X, et al. Enzyme-MOF (metal-organic framework) composites. Chem Soc Rev. 2017;46(11):3386–401.
Google Scholar
Chen Y, et al. Acid-resistant mesoporous metal-organic framework toward oral insulin delivery: protein encapsulation, protection, and release. J Am Chem Soc. 2018;140(17):5678–81.
Google Scholar
Wang S, et al. DNA-functionalized metal-organic framework nanoparticles for intracellular delivery of proteins. J Am Chem Soc. 2019;141(6):2215–9.
Google Scholar
Liang K, et al. Biomimetic mineralization of metal-organic frameworks as protective coatings for biomacromolecules. Nat Commun. 2015;6:7240.
Google Scholar
Chen G, et al. A convenient and versatile amino-acid-boosted biomimetic strategy for the nondestructive encapsulation of biomacromolecules within metal-organic frameworks. Angew Chem Int Ed Engl. 2019;58(5):1463–7.
Google Scholar
Poddar A, et al. Encapsulation, visualization and expression of genes with biomimetically mineralized zeolitic imidazolate framework-8 (ZIF-8). Small. 2019;15(36):e1902268.
Google Scholar
Jansman MMT, et al. Hemoglobin-based oxygen carriers camouflaged with membranes extracted from red blood cells: optimization and assessment of functionality. Biomater Adv. 2022;134:112691.
Google Scholar
Sun H, et al. Real-time model-based cerebral perfusion calculation for ischemic stroke. Comput Methods Programs Biomed. 2024;243: 107916.
Google Scholar
Demyanenko S, Dzreyan V, Sharifulina S. Histone deacetylases and their isoform-specific inhibitors in ischemic stroke. Biomedicines. 2021;9(10):1445.
Google Scholar
Hurd MD, et al. Current status of ischemic stroke treatment: from thrombolysis to potential regenerative medicine. Regenerat Ther. 2021;18:408–17.
Google Scholar
Wu DM, et al. Immune pathway activation in neurons triggers neural damage after stroke. Cell Rep. 2023;42(11):113368.
Google Scholar
Jun-Long H, et al. Necroptosis signaling pathways in stroke: from mechanisms to therapies. Curr Neuropharmacol. 2018;16(9):1327–39.
Google Scholar
Lin W, Powers WJ. Oxygen metabolism in acute ischemic stroke. J Cereb Blood Flow Metab. 2018;38(9):1481–99.
Google Scholar
Tirapelli CR. Oxidative stress and vascular disease. Curr Hypertens Rev. 2020;16(3):162.
Google Scholar
Zuluaga Tamayo M, et al. Astaxanthin complexes to attenuate muscle damage after in vivo femoral ischemia-reperfusion. Mar Drugs. 2019. https://doi.org/10.3390/md17060354.
Google Scholar
Deuchar GA, et al. Preclinical validation of the therapeutic potential of glasgow oxygen level dependent (GOLD) technology: a theranostic for acute stroke. Transl Stroke Res. 2019;10(5):583–95.
Google Scholar
Klaus JA, et al. Early treatment of transient focal cerebral ischemia with bovine PEGylated carboxy hemoglobin transfusion. Artificial Cell Blood Substitutes Biotechnol. 2010;38(5):223–9.
Google Scholar
Kakehata J, et al. Therapeutic potentials of an artificial oxygen-carrier, liposome-encapsulated hemoglobin, for ischemia/reperfusion-induced cerebral dysfunction in rats. J Pharmacol Sci. 2010;114(2):189–97.
Google Scholar
Kaneda S, et al. Efficacy of liposome-encapsulated hemoglobin in a rat model of cerebral ischemia. Artif Organs. 2014;38(8):650–5.
Google Scholar
Cipolla MJ, et al. Pharmacologically increasing collateral perfusion during acute stroke using a carboxyhemoglobin gas transfer agent (Sanguinate™) in spontaneously hypertensive rats. J Cereb Blood Flow Metab. 2018;38(5):755–66.
Google Scholar
Powanda DD, Chang TMS. Cross-linked polyhemoglobin-superoxide dismutase-catalase supplies oxygen without causing blood brain barrier disruption or brain edema in a rat model of transient global brain ischemia-reperfusion. Artificial Cell Blood Substitutes Biotechnol. 2002;30(1):23–37.
Google Scholar
Xie Z, et al. The protective effect of polymerized porcine hemoglobin (pPolyHb) on transient focal cerebral ischemia/reperfusion injury. Artif Cells Nanomed Biotechnol. 2015;43(3):180–5.
Google Scholar
Caswell JE, et al. A novel hemoglobin-based blood substitute protects against myocardial reperfusion injury. Am J Physiol-Heart Circulatory Physiol. 2005;288(4):H1796–801.
Google Scholar
Komatsu H, et al. Effect of hemoglobin vesicle, a cellular-type artificial oxygen carrier, on middle cerebral artery occlusion- and arachidonic acid-induced stroke models in rats. Neurosci Lett. 2007;421(2):121–5.
Google Scholar
Fukumoto D, et al. Liposome-encapsulated hemoglobin reduces the size of cerebral infarction in rats: effect of oxygen affinity. Artif Organs. 2009;33(2):159–63.
Google Scholar
Kawaguchi AT, et al. Effect of oxygen affinity of liposome-encapsulated hemoglobin on cerebral ischemia and reperfusion as detected by positron emission tomography in nonhuman primates. Artif Organs. 2017;41(4):336–45.
Google Scholar
Tomita D, et al. Covalent core-shell architecture of hemoglobin and human serum albumin as an artificial O2 carrier. Biomacromol. 2013;14(6):1816–25.
Google Scholar
Gekka M, et al. Novel hemoglobin-based oxygen carrier bound with albumin shows neuroprotection with possible antioxidant effects. Stroke. 2018;49(8):1960–8.
Google Scholar
Hosaka H, et al. Hemoglobin-albumin cluster incorporating a Pt nanoparticle: artificial O2 carrier with antioxidant activities. PLoS ONE. 2014;9(10):e110541.
Google Scholar
Wang S, et al. Pan-immune-inflammatory value predicts the 3 month outcome in acute ischemic stroke patients after intravenous thrombolysis. Curr Neurovasc Res. 2023. https://doi.org/10.2174/0115672026276427231024045957.
Google Scholar
Haupt M, et al. Preconditioning concepts for the therapeutic use of extracellular vesicles against stroke. Stem Cells Transl Med. 2023. https://doi.org/10.1093/stcltm/szad055.
Google Scholar
Yin N, et al. Engineered nanoerythrocytes alleviate central nervous system inflammation by regulating the polarization of inflammatory microglia. Adv Mater. 2022;34(27):e2201322.
Google Scholar
Shimbo D, et al. Post-ischemic intra-arterial infusion of liposome-encapsulated hemoglobin can reduce ischemia reperfusion injury. Brain Res. 2014;1554:59–66.
Google Scholar
Shimbo D, et al. Superior microvascular perfusion of infused liposome-encapsulated hemoglobin prior to reductions in infarctions after transient focal cerebral ischemia. J Stroke Cerebrovasc Dis. 2017;26(12):2994–3003.
Google Scholar
Choudhari OK, et al. Matrix metalloproteinase-9 gene polymorphism and its methylation in stroke patients. Malays J Med Sci. 2021;28(6):32–41.
Google Scholar
Viallard C, Larrivée B. Tumor angiogenesis and vascular normalization: alternative therapeutic targets. Angiogenesis. 2017;20(4):409–26.
Google Scholar
Liao C, et al. Tumor hypoxia: from basic knowledge to therapeutic implications. Semin Cancer Biol. 2023;88:172–86.
Google Scholar
Dai Y, et al. Nanoparticle design strategies for enhanced anticancer therapy by exploiting the tumour microenvironment. Chem Soc Rev. 2017;46(12):3830–52.
Google Scholar
Kwon S, et al. Nanomedicines for reactive oxygen species mediated approach: an emerging paradigm for cancer treatment. Acc Chem Res. 2019;52(7):1771–82.
Google Scholar
Shi R, Tang YQ, Miao H. Metabolism in tumor microenvironment: Implications for cancer immunotherapy. MedComm. 2020;1(1):47–68.
Google Scholar
Semenza GL. Oxygen sensing, hypoxia-inducible factors, and disease pathophysiology. Annu Rev Pathol. 2014;9:47–71.
Google Scholar
Gilkes DM, Semenza GL, Wirtz D. Hypoxia and the extracellular matrix: drivers of tumour metastasis. Nat Rev Cancer. 2014;14(6):430–9.
Google Scholar
Yang S, et al. Boosting the anti-tumor performance of disulfiram against glioblastoma by using ultrasmall nanoparticles and HIF-1α inhibitor. Compos B Eng. 2022;243:110117.
Google Scholar
Liu Y, et al. Modulation of hypoxia and redox in the solid tumor microenvironment with a catalytic nanoplatform to enhance combinational chemodynamic/sonodynamic therapy. Biomater Sci. 2023;11(5):1739–53.
Google Scholar
Huang J, et al. Oxygen-carrying nanoplatform to reprogram tumor immunosuppressive microenvironment and enhance photothermal-immunotherapy. Mater Today Bio. 2023;19:100555.
Google Scholar
Yuan CS, et al. Hypoxia-modulatory nanomaterials to relieve tumor hypoxic microenvironment and enhance immunotherapy: where do we stand? Acta Biomater. 2021;125:1–28.
Google Scholar
Telarovic I, Wenger RH, Pruschy M. Interfering with tumor hypoxia for radiotherapy optimization. J Exp Clin Cancer Res. 2021;40(1):197.
Google Scholar
Zhang J, et al. Nanotechnological strategies to increase the oxygen content of the tumor. Front Pharmacol. 2023;14:1140362.
Google Scholar
Vaupel P, Multhoff G. Fatal alliance of hypoxia-/HIF-1α-Driven microenvironmental traits promoting cancer progression. Adv Exp Med Biol. 2020;1232:169–76.
Google Scholar
Mortezaee K, Majidpoor J. The impact of hypoxia on immune state in cancer. Life Sci. 2021;286:120057.
Google Scholar
Doublier S, et al. HIF-1 activation induces doxorubicin resistance in MCF7 3-D spheroids via P-glycoprotein expression: a potential model of the chemo-resistance of invasive micropapillary carcinoma of the breast. BMC Cancer. 2012;12:4.
Google Scholar
Samanta D, et al. Hypoxia-inducible factors are required for chemotherapy resistance of breast cancer stem cells. Proc Natl Acad Sci U S A. 2014;111(50):E5429–38.
Google Scholar
Kawaguchi F, et al. Liposome-encapsulated hemoglobin improves tumor oxygenation as detected by near-infrared spectroscopy in colon carcinoma in mice. Artif Organs. 2017;41(4):327–35.
Google Scholar
Liu Y, et al. Epigenetic activation of the drug transporter OCT2 sensitizes renal cell carcinoma to oxaliplatin. Sci Trans Med. 2016;8(348):348ra97-348ra97.
Google Scholar
Zheng X, et al. Response to Comment on “epigenetic activation of the drug transporter OCT2 sensitizes renal cell carcinoma to oxaliplatin.” Sci Trans Med. 2017;9(391):eaam6298.
Google Scholar
Chen L, et al. The failure of DAC to induce OCT2 expression and its remission by hemoglobin-based nanocarriers under hypoxia in renal cell carcinoma. Theranostics. 2020;10(8):3562–78.
Google Scholar
Guo Y, et al. Cell microenvironment-controlled antitumor drug releasing-nanomicelles for GLUT1-targeting hepatocellular carcinoma therapy. ACS Appl Mater Interfaces. 2015;7(9):5444–53.
Google Scholar
Synthesis of a hemoglobin-conjugated triblock copolymer for oxygen carrying and specific recognition of cancer cells. RSC Adv., 2017; 7(76):48166–48175.
Yang, J., et al., Hypoxic tumor therapy by hemoglobin-mediated drug delivery and reversal of hypoxia-induced chemoresistance. Biomaterials, 2018. 182: p. 145–156.
Google Scholar
Sies H, Jones DP. Reactive oxygen species (ROS) as pleiotropic physiological signalling agents. Nat Rev Mol Cell Biol. 2020;21(7):363–83.
Google Scholar
Jia S, et al. Promoting reactive oxygen species generation: a key strategy in nanosensitizer-mediated radiotherapy. Nanomedicine (Lond). 2021;16(9):759–78.
Google Scholar
Huang L, et al. Photodynamic therapy for hypoxic tumors: advances and perspectives. Coord Chem Rev. 2021;438:213888.
Google Scholar
Li M, et al. Near-infrared light-initiated molecular superoxide radical generator: rejuvenating photodynamic therapy against hypoxic tumors. J Am Chem Soc. 2018;140(44):14851–9.
Google Scholar
Wang S, et al. Hemoglobins from scapharca subcrenata (Bivalvia: Arcidae) likely play an bactericidal role through their peroxidase activity. Comp Biochem Physiol B: Biochem Mol Biol. 2021;253:110545.
Google Scholar
Wang R, et al. PEGylated hollow gold nanoparticles for combined X-ray radiation and photothermal therapy in vitro and enhanced CT imaging in vivo. Nanomed Nanotechnol Biol Med. 2019;16:195–205.
Google Scholar
Goel S, Ni D, Cai W. Harnessing the power of nanotechnology for enhanced radiation therapy. ACS Nano. 2017;11(6):5233–7.
Google Scholar
Sang W, et al. Oxygen-enriched metal-phenolic X-ray nanoprocessor for cancer radio-radiodynamic therapy in combination with checkpoint blockade immunotherapy. Adv Sci. 2021;8(4):2003338.
Google Scholar
Hu CM, et al. Nanoparticle biointerfacing by platelet membrane cloaking. Nature. 2015;526(7571):118–21.
Google Scholar
Yu M, et al. Development of “smart” drug delivery systems for chemo/PDT synergistic treatment. J Mater Chem B. 2023;11(7):1416–33.
Google Scholar
Mossakowska BJ, et al. Possible mechanisms of resistance development to photodynamic therapy (PDT) in vulvar cancer cells. Int J Mol Sci. 2022. https://doi.org/10.3390/ijms232314689.
Google Scholar
Dang J, et al. Manipulating tumor hypoxia toward enhanced photodynamic therapy (PDT). Biomater Sci. 2017;5(8):1500–11.
Google Scholar
Zhou Z, et al. Reactive oxygen species generating systems meeting challenges of photodynamic cancer therapy. Chem Soc Rev. 2016;45(23):6597–626.
Google Scholar
Feng L, et al. Multifunctional UCNPs@MnSiO(3)@g-C(3)N(4) nanoplatform: improved ROS generation and reduced glutathione levels for highly efficient photodynamic therapy. Biomater Sci. 2017;5(12):2456–67.
Google Scholar
Chae YC, et al. Mitochondrial akt regulation of hypoxic tumor reprogramming. Cancer Cell. 2016;30(2):257–72.
Google Scholar
Liang T, et al. Adapting and remolding: orchestrating tumor microenvironment normalization with photodynamic therapy by size transformable nanoframeworks. Angew Chem Int Ed Engl. 2021;60(20):11464–73.
Google Scholar
Shi X, et al. Hemoglobin-mediated biomimetic synthesis of paramagnetic O(2)-evolving theranostic nanoprobes for MR imaging-guided enhanced photodynamic therapy of tumor. Theranostics. 2020;10(25):11607–21.
Google Scholar
Wang S, et al. Synthesis of hemoglobin conjugated polymeric micelle: a ZnPc carrier with oxygen self-compensating ability for photodynamic therapy. Biomacromol. 2015;16(9):2693–700.
Google Scholar
Luo Z, et al. Self-monitoring artificial red cells with sufficient oxygen supply for enhanced photodynamic therapy. Sci Rep. 2016;6:23393.
Google Scholar
Cao H, et al. An assembled nanocomplex for improving both therapeutic efficiency and treatment depth in photodynamic therapy. Angew Chem Int Ed Engl. 2018;57(26):7759–63.
Google Scholar
Chen Z, et al. Bioinspired hybrid protein oxygen nanocarrier amplified photodynamic therapy for eliciting anti-tumor immunity and abscopal effect. ACS Nano. 2018;12(8):8633–45.
Google Scholar
Steeg PS. Tumor metastasis: mechanistic insights and clinical challenges. Nat Med. 2006;12(8):895–904.
Google Scholar
Xu T, et al. Enhanced ferroptosis by oxygen-boosted phototherapy based on a 2-in-1 nanoplatform of ferrous hemoglobin for tumor synergistic therapy. ACS Nano. 2020;14(3):3414–25.
Google Scholar
Wang H, et al. Discovery of ML210-Based glutathione peroxidase 4 (GPX4) degrader inducing ferroptosis of human cancer cells. Eur J Med Chem. 2023;254:115343.
Google Scholar
Hu H, et al. Emerging nanomedicine-enabled/enhanced nanodynamic therapies beyond traditional photodynamics. Adv Mater. 2021;33(12):e2005062.
Google Scholar
Jiang Q, et al. A hydrogen peroxide economizer for on-demand oxygen production-assisted robust sonodynamic immunotherapy. Theranostics. 2022;12(1):59–75.
Google Scholar
Yin T, et al. Hypoxia-alleviated sonodynamic therapy based on a hybrid protein oxygen carrier to enhance tumor inhibition. Biomater Sci. 2021;10(1):294–305.
Google Scholar
Pan ZQ, et al. Construction and evaluation of zeolitic imidazolate framework-encapsulated hemoglobin microparticles as oxygen carriers. ACS Appl Bio Mater. 2023;6(4):1471–8.
Google Scholar
Liang G, et al. Reduction of platinum(IV) prodrug hemoglobin nanoparticles with deeply penetrating ultrasound radiation for tumor-targeted therapeutically enhanced anticancer therapy. Angew Chem Int Ed. 2023;62(22):e202301074.
Google Scholar
Mortezaee K, Majidpoor J. The impact of hypoxia on extracellular vesicle secretome profile of cancer. Med Oncol. 2023;40(5):128.
Google Scholar
Wijekoon A, Fountas-Davis N, Leipzig ND. Fluorinated methacrylamide chitosan hydrogel systems as adaptable oxygen carriers for wound healing. Acta Biomater. 2013;9(3):5653–64.
Google Scholar
Younis I. Role of oxygen in wound healing. J Wound Care. 2020;29(Sup5b):S4-s10.
Google Scholar
Gupta S, et al. Dynamic role of oxygen in wound healing: a microbial, immunological, and biochemical perspective. Arch Razi Inst. 2022;77(2):513–23.
Google Scholar
Sen CK. Wound healing essentials: let there be oxygen. Wound Repair Regenerat. 2009;17(1):1–18.
Google Scholar
Zhu Y, et al. Roxadustat promotes angiogenesis through HIF-1α/VEGF/VEGFR2 signaling and accelerates cutaneous wound healing in diabetic rats. Wound Repair Regen. 2019;27(4):324–34.
Google Scholar
Thangarajah H, et al. HIF-1α dysfunction in diabetes. Cell Cycle. 2010;9(1):75–9.
Google Scholar
Fosen KM, Thom SR. Hyperbaric oxygen, vasculogenic stem cells, and wound healing. Antioxid Redox Signal. 2014;21(11):1634–47.
Google Scholar
Wang X, et al. In situ 3D bioprinting living photosynthetic scaffolds for autotrophic wound healing. Research. 2022. https://doi.org/10.34133/2022/9794745.
Google Scholar
Kang JI, Park KM. Oxygen-supplying syringe to create hyperoxia-inducible hydrogels for in situ tissue regeneration. Biomaterials. 2023;293:121943.
Google Scholar
Zhao E, et al. Separable microneedles with photosynthesis-driven oxygen manufactory for diabetic wound healing. ACS Appl Mater Interfaces. 2023;15(6):7725–34.
Google Scholar
Chen H, et al. Dissolved oxygen from microalgae-gel patch promotes chronic wound healing in diabetes. Sci Adv. 2020;6(20):eaba4311.
Google Scholar
Wang T, et al. Combined antioxidant-antibiotic treatment for effectively healing infected diabetic wounds based on polymer vesicles. ACS Nano. 2021;15(5):9027–38.
Google Scholar
Hauck S, et al. Collagen/hyaluronan based hydrogels releasing sulfated hyaluronan improve dermal wound healing in diabetic mice via reducing inflammatory macrophage activity. Bioact Mater. 2021;6(12):4342–59.
Google Scholar
Wang S, et al. Nanoenzyme-reinforced injectable hydrogel for healing diabetic wounds infected with multidrug resistant bacteria. Nano Lett. 2020;20(7):5149–58.
Google Scholar
Jia Z, et al. Bioinspired conductive silk microfiber integrated bioelectronic for diagnosis and wound healing in diabetes. Adv Func Mater. 2021;31(19):2010461.
Google Scholar
Chen Y, et al. Research advances in smart responsive-hydrogel dressings with potential clinical diabetic wound healing properties. Mil Med Res. 2023;10(1):37.
Google Scholar
Thangarajah H, et al. The molecular basis for impaired hypoxia-induced VEGF expression in diabetic tissues. Proc Natl Acad Sci U S A. 2009;106(32):13505–10.
Google Scholar
Fukui T, et al. Liposome-encapsulated hemoglobin accelerates skin wound healing in diabetic dB/dB mice. Artif Organs. 2017;41(4):319–26.
Google Scholar
Rius J, et al. NF-kappaB links innate immunity to the hypoxic response through transcriptional regulation of HIF-1alpha. Nature. 2008;453(7196):807–11.
Google Scholar
Jin L, et al. An NIR photothermal-responsive hybrid hydrogel for enhanced wound healing. Bioact Mater. 2022;16:162–72.
Google Scholar
Peng Y, et al. Construction of heparin-based hydrogel incorporated with Cu5.4O ultrasmall nanozymes for wound healing and inflammation inhibition. Bioact Mater. 2021;6(10):3109–24.
Google Scholar
Waris TS, et al. Chitosan-sodium percarbonate-based hydrogels with sustained oxygen release potential stimulated angiogenesis and accelerated wound healing. J Biomed Mater Res B Appl Biomater. 2023. https://doi.org/10.1002/jbm.b.35344.
Google Scholar
Yang Z, et al. Oxygen-generating hydrogels as oxygenation therapy for accelerated chronic wound healing. Adv Healthc Mater. 2023. https://doi.org/10.1002/adhm.202302391.
Google Scholar
Shiekh PA, Singh A, Kumar A. Oxygen-releasing antioxidant cryogel scaffolds with sustained oxygen delivery for tissue engineering applications. ACS Appl Mater Interfaces. 2018;10(22):18458–69.
Google Scholar
Frykberg R, et al. Use of Topical Oxygen Therapy in Wound Healing. J Wound Care. 2023;32(Sup8b):S1-s32.
Google Scholar
Liu Y, et al. Responsive porous microcarriers with controllable oxygen delivery for wound healing. Small. 2019;15(21):e1901254.
Google Scholar
Zhang X, et al. Encoded microneedle arrays for detection of skin interstitial fluid biomarkers. Adv Mater. 2019;31(37):e1902825.
Google Scholar
Li W, et al. Rapidly separable microneedle patch for the sustained release of a contraceptive. Nat Biomed Eng. 2019;3(3):220–9.
Google Scholar
Priya S, et al. Concurrent occurrence of lobular capillary haemangioma and port-wine stain: a case report and literature review. Cureus. 2023;15(5):e38642.
Google Scholar
Demirel Öğüt N. Acquired plantar port-wine stain (Fegeler syndrome) following prolonged standing. J Cosmet Dermatol. 2022;21(10):5234–5.
Google Scholar
Jiang F, et al. Influence of port-wine stains on quality of life of children and their parents. Acta Derm Venereol. 2021;101(8):adv00516.
Google Scholar
Artzi O, et al. Treatment of port wine stain with Tixel-induced rapamycin delivery following pulsed dye laser application. Dermatol Ther. 2020;33(1):e13172.
Google Scholar
Sabeti S, et al. Consensus statement for the management and treatment of port-wine birthmarks in sturge-weber syndrome. JAMA Dermatol. 2021;157(1):98–104.
Google Scholar
Yang C, et al. Mapping port wine stain in vivo by optical coherence tomography angiography and multi-metric characterization. Opt Express. 2023;31(9):13613–26.
Google Scholar
Sakai H, et al. O2 release from Hb vesicles evaluated using an artificial, narrow O2-permeable tube: comparison with RBCs and acellular Hbs. Am J Physiol-Heart Circulatory Physiol. 2003;285(6):H2543–51.
Google Scholar
Rikihisa N, et al. Artificial red blood cells as potential photosensitizers in dye laser treatment against port-wine stains. J Funct Biomater. 2017;8(2):14.
Google Scholar
Ranjbar A, et al. Machine learning models for predicting pre-eclampsia: a systematic review protocol. BMJ Open. 2023;13(9):e074705.
Google Scholar
Davidson KW, et al. Screening for gestational diabetes: us preventive services task force recommendation statement. JAMA. 2021;326(6):531–8.
Google Scholar
Henderson JT, et al. Preeclampsia screening: evidence report and systematic review for the US preventive services task force. JAMA. 2017;317(16):1668–83.
Google Scholar
Burton GJ, et al. Rheological and physiological consequences of conversion of the maternal spiral arteries for uteroplacental blood flow during human pregnancy. Placenta. 2009;30(6):473–82.
Google Scholar
Fruci S, et al. Pravastatin for severe preeclampsia with growth restriction: Placental findings and infant follow-up. Eur J Obstet Gynecol Reprod Biol. 2023;283:37–42.
Google Scholar
Myatt L, Webster RP. Vascular biology of preeclampsia. J Thromb Haemost. 2009;7(3):375–84.
Google Scholar
Powe CE, Levine RJ, Karumanchi SA. Preeclampsia, a disease of the maternal endothelium: the role of antiangiogenic factors and implications for later cardiovascular disease. Circulation. 2011;123(24):2856–69.
Google Scholar
Cotechini T, et al. Inflammation in rat pregnancy inhibits spiral artery remodeling leading to fetal growth restriction and features of preeclampsia. J Exp Med. 2014;211(1):165–79.
Google Scholar
Kawaguchi AT, et al. Liposome-encapsulated hemoglobin reduces the size of cerebral infarction in the rat. Stroke. 2007;38(5):1626–32.
Google Scholar
Chang TMS. Therapeutic applications of polymeric artificial cells. Nat Rev Drug Discovery. 2005;4(3):221–35.
Google Scholar
Ohta H, et al. Potential new non-invasive therapy using artificial oxygen carriers for pre-eclampsia. J Funct Biomater. 2017. https://doi.org/10.3390/jfb8030032.
Google Scholar
Mysak J, et al. Porphyromonas gingivalis: major periodontopathic pathogen overview. J Immunol Res. 2014;2014:476068.
Google Scholar
Yang J, et al. Porphyromonas gingivalis oral infection promote T helper 17/Treg imbalance in the development of atherosclerosis. J Dent Sci. 2017;12(1):60–9.
Google Scholar
Paramaesvaran M, et al. Porphyrin-Mediated Cell Surface Heme Capture from Hemoglobin by <i>Porphyromonas gingivalis</i>. J Bacteriol. 2003;185(8):2528–37.
Google Scholar
Bai L, et al. Oxyhemoglobin-based nanophotosensitizer for specific and synergistic photothermal and photodynamic therapies against porphyromonas gingivalis oral infection. ACS Biomater Sci Eng. 2023;9(1):485–97.
Google Scholar
Mao C, et al. Local photothermal/photodynamic synergistic therapy by disrupting bacterial membrane to accelerate reactive oxygen species permeation and protein leakage. ACS Appl Mater Interfaces. 2019;11(19):17902–14.
Google Scholar
Zhang H, et al. Dual-mode antibacterial conjugated polymer nanoparticles for photothermal and photodynamic therapy. Macromol Biosci. 2020;20(2):e1900301.
Google Scholar
Hu X, et al. Synergistic antibacterial strategy based on photodynamic therapy: Progress and perspectives. Chem Eng J. 2022;450:138129.
Google Scholar
Paciello A, et al. Hemoglobin-conjugated gelatin microsphere as a smart oxygen releasing biomaterial. Adv Healthc Mater. 2016;5(20):2655–66.
Google Scholar
Jones GL, et al. Time course and quantification of pancreatic islet revasculariztion following intraportal transplantation. Cell Transplant. 2007;16(5):505–16.
Google Scholar
Rodriguez-Brotons A, et al. Impact of pancreatic rat islet density on cell survival during hypoxia. J Diabetes Res. 2016;2016:3615286.
Google Scholar
Okere B, et al. Cell therapies for pancreatic beta-cell replenishment. Ital J Pediatr. 2016;42(1):62.
Google Scholar
Mouré A, et al. Extracellular hemoglobin combined with an O(2) -generating material overcomes O(2) limitation in the bioartificial pancreas. Biotechnol Bioeng. 2019;116(5):1176–89.
Google Scholar
Le Pape F, et al. Advancement in recombinant protein production using a marine oxygen carrier to enhance oxygen transfer in a CHO-S cell line. Artif Cells Nanomed Biotechnol. 2015;43(3):186–95.
Google Scholar
Sue C-Y, Tsai N-C. Human powered MEMS-based energy harvest devices. Appl Energy. 2012;93:390–403.
Google Scholar
Zebda A, et al. Mediatorless high-power glucose biofuel cells based on compressed carbon nanotube-enzyme electrodes. Nat Commun. 2011;2:370.
Google Scholar
Weltin A, et al. Polymer-based, flexible glutamate and lactate microsensors for in vivo applications. Biosens Bioelectron. 2014;61:192–9.
Google Scholar
Chen H, et al. In Situ Engineering of Intracellular Hemoglobin for Implantable High-Performance Biofuel Cells. Angew Chem Int Ed Engl. 2019;58(20):6663–8.
Google Scholar
Rikihisa N, et al. Artificial red blood cells as potential photosensitizers in dye laser treatment against port-wine stains. J Funct Biomater. 2017. https://doi.org/10.3390/jfb8020014.
Google Scholar